In cancer, both PEPT1 and PEPT2 expressions have been reported for several different tumor tissues (bladder, colorectal, and hepatocellular cancer) and cell lines deriving from different tumor entities such as gastric, prostate, pancreatic, and hepatocellular carcinomas [193,194,195,196,197,198]. This evidence concerns the gene SLC15A2 and hepatocellular carcinoma.